Literature DB >> 1402792

Biological activities and chemical composition of a cytotoxin of Klebsiella oxytoca.

J Minami1, S Saito, T Yoshida, T Uemura, A Okabe.   

Abstract

A low-molecular-mass cytotoxin produced by Klebsiella oxytoca isolated previously from patients with antibiotic-associated haemorrhagic enterocolitis was purified, and its biological and chemical properties were elucidated. The toxin inhibited the syntheses of DNA and RNA by HEp-2 cells dose-dependently, whereas protein synthesis was only slightly inhibited, as measured by the incorporation of radioactive precursors. When synchronously cultured HEp-2 cells were examined in the presence of cytotoxin, inhibition of DNA synthesis occurred promptly within 5 h, but cell-rounding, the earliest visible morphological change, was not observed until 6 h after exposure. The intracellular levels of ATP decreased with an approximately similar time course. These results suggest that cytotoxicity toward HEp-2 cells is primarily due to the inhibitory effect of the cytotoxin on nucleic acid synthesis, possibly on DNA synthesis. Cell rounding and cell death were induced even in the absence of the cytotoxin after incubation with the cytotoxin for 6 h. The cytotoxin was heat-labile, cytotoxic activity decreasing to 50% of the initial level on heating at 70 degrees C for 20 min. Plasmids were extracted from three strains of K. oxytoca producing the cytotoxin and analysed by agarose gel electrophoresis. Two strains possessed plasmids of different sizes, but one strain possessed no plasmid, indicating that the cytotoxin is probably chromosomally encoded. Analysis by NMR and FAB-mass-spectrometry revealed that the molecular mass of the cytotoxin should be 217.1062 Da (exact mass), its molecular formula being C8H15O4N3.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1402792     DOI: 10.1099/00221287-138-9-1921

Source DB:  PubMed          Journal:  J Gen Microbiol        ISSN: 0022-1287


  7 in total

1.  A study of the prevalence of cytotoxic and non-cytotoxic Klebsiella oxytoca fecal colonization in two patient populations.

Authors:  Stephen A Smith; Sarah J Campbell; Duncan Webster; Michael Curley; Desmond Leddin; Kevin R Forward
Journal:  Can J Infect Dis Med Microbiol       Date:  2009       Impact factor: 2.471

Review 2.  Klebsiella oxytoca and Emerging Nosocomial Infections.

Authors:  Nakul Neog; Upasana Phukan; Minakshi Puzari; Mohan Sharma; Pankaj Chetia
Journal:  Curr Microbiol       Date:  2021-03-03       Impact factor: 2.188

3.  Cytotoxic effects of Klebsiella oxytoca strains isolated from patients with antibiotic-associated hemorrhagic colitis or other diseases caused by infections and from healthy subjects.

Authors:  Martina M Joainig; Gregor Gorkiewicz; Eva Leitner; Paul Weberhofer; Ines Zollner-Schwetz; Irmgard Lippe; Gebhard Feierl; Robert Krause; Thomas Hinterleitner; Ellen L Zechner; Christoph Högenauer
Journal:  J Clin Microbiol       Date:  2010-01-06       Impact factor: 5.948

4.  Enterotoxic activity of Klebsiella oxytoca cytotoxin in rabbit intestinal loops.

Authors:  J Minami; S Katayama; O Matsushita; H Sakamoto; A Okabe
Journal:  Infect Immun       Date:  1994-01       Impact factor: 3.441

Review 5.  Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors.

Authors:  R Podschun; U Ullmann
Journal:  Clin Microbiol Rev       Date:  1998-10       Impact factor: 26.132

6.  A tricyclic pyrrolobenzodiazepine produced by Klebsiella oxytoca is associated with cytotoxicity in antibiotic-associated hemorrhagic colitis.

Authors:  Herman Tse; Qiangshuai Gu; Kong-Hung Sze; Ivan K Chu; Richard Y-T Kao; Kam-Chung Lee; Ching-Wan Lam; Dan Yang; Sherlock Shing-Chiu Tai; Yihong Ke; Elaine Chan; Wan-Mui Chan; Jun Dai; Sze-Pui Leung; Suet-Yi Leung; Kwok-Yung Yuen
Journal:  J Biol Chem       Date:  2017-09-26       Impact factor: 5.157

7.  Cytotoxic and pathogenic properties of Klebsiella oxytoca isolated from laboratory animals.

Authors:  Alison Darby; Kvin Lertpiriyapong; Ujjal Sarkar; Uthpala Seneviratne; Danny S Park; Eric R Gamazon; Chara Batchelder; Cheryl Cheung; Ellen M Buckley; Nancy S Taylor; Zeli Shen; Steven R Tannenbaum; John S Wishnok; James G Fox
Journal:  PLoS One       Date:  2014-07-24       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.